Expression of the FGFR1 gene in human breast-carcinoma cells
about
Targeting RTK Signaling Pathways in CancerFunctional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancersDiscovery of Novel Fibroblast Growth Factor Receptor 1 Kinase Inhibitors by Structure-Based Virtual ScreeningFGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancerSignaling initiated by overexpression of the fibroblast growth factor receptor-1 investigated by mass spectrometryNovel Strategies to Improve the Endocrine Therapy of Breast Cancer.New prognostic histological parameter of invasive ductal carcinoma of the breast: clinicopathological significance of fibrotic focus.Fibroblast growth factors in cancer: therapeutic possibilities.Rationale for targeting fibroblast growth factor receptor signaling in breast cancerFibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinomaExpression of acidic fibroblast growth factor (aFGF) and fibroblast growth factor receptor 4 (FGFR4) in breast fibroadenomas.Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer.RasGAP Shields Akt from Deactivating Phosphatases in Fibroblast Growth Factor Signaling but Loses This Ability Once Cleaved by Caspase-3.Expression of fibroblast growth factor 1 is lower in breast cancer than in the normal human breast.Challenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancer.Fibroblast growth factor receptor 1 promotes MG63 cell proliferation and is associated with increased expression of cyclin-dependent kinase 1 in osteosarcomaThe location of acidic fibroblast growth factor in the breast is dependent on the activity of proteases present in breast cancer tissueKeratinocyte growth factor expression and activity in cancer: implications for use in patients with solid tumors.FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma.ERBB-2 overexpression confers PI 3' kinase-dependent invasion capacity on human mammary epithelial cells.Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy.Genome-wide copy number aberrations and HER2 and FGFR1 alterations in primary breast cancer by molecular inversion probe microarray.Fibroblast growth factors and their receptors in cancer.Role of FGF receptors as an emerging therapeutic target in lung squamous cell carcinoma.Transitions from mono- to co- to tri-culture uniquely affect gene expression in breast cancer, stromal, and immune compartments.Mechanisms of FGFR3 actions in endocrine resistant breast cancer.Reciprocal relationship in gene expression between FGFR1 and FGFR3: implication for tumorigenesis.Constitutive expression of FGF2/bFGF in non-tumorigenic human prostatic epithelial cells results in the acquisition of a partial neoplastic phenotype.FGF7 protein expression in human breast carcinomas.Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?Signal transduction pathways triggered by fibroblast growth factor receptor 1 expressed in Xenopus laevis oocytes after fibroblast growth factor 1 addition. Role of Grb2, phosphatidylinositol 3-kinase, Src tyrosine kinase, and phospholipase Cgamma.The correlations between the expression of FGFR4 protein and clinicopathological parameters as well as prognosis of gastric cancer patients.[Advanced research of fibroblast growth factor receptor in non-small cell lung cancer].Significance of basic fibroblast growth factor and fibroblast growth factor receptor protein expression in the formation of fibrotic focus in invasive ductal carcinoma of the breast.
P2860
Q26781278-DE08E0D6-7E33-4A17-9BDD-482CFE2E533DQ26998955-700E7AD6-55AF-4DC9-ADAF-3E3D5FA82A99Q27659340-4D37FD9F-974B-4365-9268-2467B884264FQ27851554-F208D923-BF2B-4D08-871C-D676D2E38D5FQ28211506-44BD4C89-8C42-4AB8-9B6A-039DDCE43CAFQ33727284-1F215FA3-28B8-425F-A7C1-DB3F6F06FB29Q33940503-D3A30460-6BEA-4C25-9D8F-59274A0EE3ECQ34837255-00521FE3-B591-43A9-9EB6-F405D0098947Q35131258-BFCF65D2-6299-46C7-93F0-DEA1206A4C4BQ35364559-72F28FF9-787A-40CD-B162-0F9FC7959195Q35397220-863DBBD0-CC88-4CEB-AB7C-6D17846F93F9Q35763505-CA4EA5FC-8C1D-4E43-8197-73548DE7130BQ35925830-B44AB17A-ED62-4A9B-B799-8F4988B29DD4Q36081755-A77C88C8-F47F-455D-9DB6-91CFE194DAD4Q36245320-5BB45460-9107-4924-8EE6-3E9B7F9FA5B7Q36390216-8F6BE388-A5A9-4327-88AB-D6067B3001C2Q36421743-4DAE12DA-330F-4C11-B861-71AB9433E8E4Q36513663-248F8EC7-136E-4D1B-A011-1314A0EB8ECFQ36524946-9CF6BA53-2E6B-48CF-8DDA-4D2691894F53Q36621254-E4D5316E-1FFD-44CA-8BEA-B772723029F5Q37635256-7D798B95-3EFC-4613-9256-A3501143DAB6Q37706844-36457500-7E3E-4835-8BDE-ACB1EBADB5B6Q37895306-0034B01F-E988-4E76-94D2-7093EA2466B8Q38087392-3D969B44-584E-4CC6-8C75-8123964CC051Q38757103-35FDBCCE-0D05-453B-92D4-8881B7188DADQ39500283-074430A9-09EA-4A3E-AFD9-8BF0A824AB31Q40488970-E2A3448A-55CA-45A9-A1AC-EC43B4CF4F1AQ41098573-C136F799-AA1F-400D-B9EB-CE31E0CCF41FQ44732103-31EF93D5-772D-421B-97E6-28A2C9CF9C19Q47164059-7D129F1A-6800-4984-ADC3-A32D5AEA048DQ50723011-8A8F1F8C-8A38-497A-8134-60E03F62EF1AQ50944921-F4097537-90B6-4190-B693-DE97BE95A4DAQ54600919-C93B5C7B-A47B-4EE5-8330-07921FA04926Q55310374-12FD2975-7FE4-42A2-AB0B-9E23F54DB279
P2860
Expression of the FGFR1 gene in human breast-carcinoma cells
description
1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1994
@ast
im November 1994 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1994/11/01)
@sk
vědecký článek publikovaný v roce 1994
@cs
wetenschappelijk artikel (gepubliceerd op 1994/11/01)
@nl
наукова стаття, опублікована в листопаді 1994
@uk
مقالة علمية (نشرت في نوفمبر 1994)
@ar
name
Expression of the FGFR1 gene in human breast-carcinoma cells
@ast
Expression of the FGFR1 gene in human breast-carcinoma cells
@en
Expression of the FGFR1 gene in human breast-carcinoma cells
@nl
type
label
Expression of the FGFR1 gene in human breast-carcinoma cells
@ast
Expression of the FGFR1 gene in human breast-carcinoma cells
@en
Expression of the FGFR1 gene in human breast-carcinoma cells
@nl
prefLabel
Expression of the FGFR1 gene in human breast-carcinoma cells
@ast
Expression of the FGFR1 gene in human breast-carcinoma cells
@en
Expression of the FGFR1 gene in human breast-carcinoma cells
@nl
P2093
P2860
P356
P1476
Expression of the FGFR1 gene in human breast-carcinoma cells
@en
P2093
D. Birnbaum
F. Penault-Llorca
J. Adelaide
J. Jacquemier
J. Planche
O. deLapeyriere
P2860
P304
P356
10.1002/IJC.2910590314
P577
1994-11-01T00:00:00Z